Ubs Group Ag Creative Medical Technology Holdings, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.35 - $0.5 $7,042 - $10,061	20,122 Added 186.63%	30,904 $11,000
Q3 2022 Nov 10, 2022	BUY	$0.55 - $0.78 $5,930 - $8,409	10,782 New	10,782 $5,000
Q2 2022 Aug 10, 2022	SELL	$0.62 - $3.66 $5,679 - $33,525	-9,160 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.33 - $4.54 $12,182 - $41,586	9,160 New	9,160 $36,000

Ticker CELZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,070,300
Market Cap $53.6M
Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.